These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11506775)

  • 1. Treatment of nosocomial pneumonia: an experience with meropenem.
    Santos SS; Machado FR; Kiffer CR; Barone AA
    Braz J Infect Dis; 2001 Jun; 5(3):124-9. PubMed ID: 11506775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
    Kollef MH; Nováček M; Kivistik Ü; Réa-Neto Á; Shime N; Martin-Loeches I; Timsit JF; Wunderink RG; Bruno CJ; Huntington JA; Lin G; Yu B; Butterton JR; Rhee EG
    Lancet Infect Dis; 2019 Dec; 19(12):1299-1311. PubMed ID: 31563344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
    Alvarez Lerma F;
    Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.
    Souweine B; Veber B; Bedos JP; Gachot B; Dombret MC; Regnier B; Wolff M
    Crit Care Med; 1998 Feb; 26(2):236-44. PubMed ID: 9468159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial.
    Berman SJ; Fogarty CM; Fabian T; Melnick D; Lesky W;
    J Chemother; 2004 Aug; 16(4):362-71. PubMed ID: 15332712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.
    Finch RG; Pemberton K; Gildon KM
    J Chemother; 1998 Feb; 10(1):35-46. PubMed ID: 9531074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
    Alvarez Lerma F;
    J Chemother; 2001 Feb; 13(1):70-81. PubMed ID: 11233804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Actualities of adults' ventilator-associated pneumonia].
    Svediene S; Ivaskevicius J
    Medicina (Kaunas); 2006; 42(2):91-7. PubMed ID: 16528124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
    Kollef MH; Ward S
    Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
    Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
    Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing two heat and moisture exchangers, one hydrophobic and one hygroscopic, on humidifying efficacy and the rate of nosocomial pneumonia.
    Thomachot L; Viviand X; Arnaud S; Boisson C; Martin CD
    Chest; 1998 Nov; 114(5):1383-9. PubMed ID: 9824019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
    Sieger B
    Crit Care Med; 1998 Aug; 26(8):1462-3. PubMed ID: 9710113
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients.
    Tokuyasu H; Harada T; Watanabe E; Okazaki R; Touge H; Kawasaki Y; Shimizu E
    Intern Med; 2009; 48(3):129-35. PubMed ID: 19182422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
    Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
    J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
    Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of meropenem in the treatment of pneumonia in the critical patient].
    León Gil C; Alvarez Lerma F; Sánchez Jiménez MA
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():62-8. PubMed ID: 9410072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.